Nuvectis Pharma Inc is a biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
NVCT is expected to report earnings to fall 14.43% to -25 cents per share on November 11
Q3'25
Est.
$-0.26
Q2'25
Missed
by $0.05
Q1'25
Beat
by $0.53
Q4'24
Missed
by $0.09
Q3'24
Beat
by $0.01
The last earnings report on August 05 showed earnings per share of -30 cents, missing the estimate of -25 cents. With 277.12K shares outstanding, the current market capitalization sits at 128.91M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NVCT showed earnings on August 05, 2025. You can read more about the earnings report here.